Scholarly article on topic 'PReS-FINAL-1018: Can the CD4/CD8β ratio be used as a predictive biomarker in extended-to-be oligoarticular JIA?'

PReS-FINAL-1018: Can the CD4/CD8β ratio be used as a predictive biomarker in extended-to-be oligoarticular JIA? Academic research paper on "Veterinary science"

0
0
Share paper
Academic journal
Pediatr Rheumatol
OECD Field of science
Keywords
{""}

Academic research paper on topic "PReS-FINAL-1018: Can the CD4/CD8β ratio be used as a predictive biomarker in extended-to-be oligoarticular JIA?"

De Leeuw et al. Pediatric Rheumatology 2013, 11(Suppl 2):P15

http://www.ped-rheum.com/content/11/S2/P15 * % PEDIATRIC

RHEUMATOLOGY

POSTER PRESENTATION Open Access

PReS-FINAL-1018: Can the CD4/CD8P ratio be used as a predictive biomarker in extended-to-be oligoarticular JIA?

1 7* 111 1 ^ 1 1

S De Leeuw ' , B Thirugnanabalan , H Varsani , F Warden , N Makengo , J Lewis , A Pesenacker, L Wedderburn

From 20th Pediatric Rheumatology European Society (PReS) Congress Ljubljana, Slovenia. 25-29 September 2013

Introduction

Predicting disease course in Juvenile Idiopathic Arthritis (JIA) is difficult. During the first 6 months of oligoarticular JIA (O-JIA) disease presents with 4 or fewer affected joints, however after 6 or more months severity might increase with more than 4 joints involved (extended OJIA), or persist with 4 or fewer joints affected (persistent O-JIA). However patients do not show any clinical differences at onset making a decision on treatment strategy difficult before extension occurs. It has previously been shown that the CD4/CD8 T cell ratio in extended-to-be patients (samples before extension has occurred) is lower compared to those who persist (Hunter et al 2010), and thus might be a useful biomarker in predicting the course of disease. However measuring this cell ratio currently requires specialized expertise. To translate the measurement of the CD4/8 synovial T cell ratio as a biomarker a method is needed, which could be used in a wide range of hospital facilities, hence a real-time quantitative PCR (qPCR) method was tested.

Objectives

The aim of this study was to measure CD4 and CD8 mRNA in whole synovial fluid collected at therapeutic joint injection and to compare it to the gold standard of flow cytometry using mononuclear cells.

transcripts were measured by qPCR. Simultaneously peripheral blood mononuclear cells (PBMC) and SFMC were isolated using density gradient centrifugation and stained with CD3, CD4, CD8b and CD8a for flow cytometry.

Results

Validating previous results, the CD4/CD8 T-cell ratio measured by flow cytometry was significantly lower in SFMC than in healthy adult PBMC. Measurement of CD4/8 ratio by qPCR and flow cytometry showed some correlation in healthy adult PBMC. However CD4/CD8 ratios by qPCR were higher in SF samples compared to healthy control PBMC. This was driven by increased CD4 measurements by qPCR in SF samples.

Conclusion

Taken together these data show a trend to a correlation of qPCR and flow cytometry methods in healthy adult control samples. The increased level of CD4 transcript in SF measured by qPCR might well be due to the abundance of neutrophils and monocytes, which are/may be discarded during preparation of SFMC for flow cytometry. Whether qPCR measurement of CD4/CD8 ratio can be used as a predictive biomarker for severity of disease course in O-JIA remains to be seen, and will be assessed once clinical follow-up data is available.

Methods

A total of 40 healthy adult blood and 20 patient synovial fluid (SF) samples were included in this study. cDNA was generated from total RNA extracted from Tempus vacu-tainers using whole blood or SF. CD4, CD8b and GAPDH

Rheumatology department, UCL Institute of Child Health, London, UK Full list of author information is available at the end of the article

Disclosure of interest

None declared.

Authors' details

Rheumatology department, UCL Institute of Child Health, London, UK. 2Life Siences, HAN University of Applied Sciences, Nijmegen, The Netherlands. 3Immunobiology department, UCL Institute of Child Health, London, UK.

© 2013 De Leeuw et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative . I Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and Ulal reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

De Leeuw et al. Pediatric Rheumatology 2013, 11(Suppl 2):P15 http://www.ped-rheum.com/content/11/S2/P15

Page 2 of 2

Published: 5 December 2013

doi:10.1186/1546-0096-11-S2-P15

Cite this article as: De Leeuw et al: PReS-FINAL-1018: Can the CD4/ CD8p ratio be used as a predictive biomarker in extended-to-be oligoarticular JIA? Pediatric Rheumatology 2013 11 (Suppl 2):P15.

Submit your next manuscript to BioMed Central and take full advantage of:

• Convenient online submission

• Thorough peer review

• No space constraints or color figure charges

• Immediate publication on acceptance

• Inclusion in PubMed, CAS, Scopus and Google Scholar

• Research which is freely available for redistribution

Submit your manuscript at fpntral

www.biomedcentral.com/submit v-enudi